Dr Addeo received his training at the University of Turin (Italy)and completed a MD in oncology at the University school  of medicine of Turin (Italy). Dr Addeo has been working on Thoracic malignancies since 2006 and he has been the head of the thoracic cancer Unit  at the Geneva University Hospital.  he counts more than 100 publications on international peer-reviewed journal. He has been deeply involved in clinical trials and drug developments.

Dr Alfredo Addeo has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Amgen, AstraZeneca, Astellas, MSD, Novartis, Roche and Pfizer.